Sorry, you need to enable JavaScript to visit this website.

METRONIDAZOLE (metronidazole injection, USP) Principal Display Panel

IM-0279

Bag NDC 0409-7811-24

 


PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label

TO OPEN – TEAR AT NOTCH
NDC 0409-7811-24
One Unit

METRONIDazole
Injection, USP
Rx only

500 mg (5 mg/mL)

Each mL contains metronidazole 5 mg; sodium chloride 7.9 mg; dibasic sodium
phosphate, anhydrous 0.48 mg; citric acid, anhydrous 0.23 mg. Sodium 14 mEq/100 mL.
314 mOsmol/liter (CALC.). pH 5.8 (4.5 to 7.0).

ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION

DO NOT REFRIGERATE

Single-dose container. For I.V. use. Usual dose: See insert. Sterile, nonpyrogenic.
Protect from light. Use only if solution is clear. After removing the overwrap, check
for minute leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired. Must not be used in series connections.

The overwrap is a moisture barrier. Do not remove unit from overwrap until ready for
use. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to 77°F). [See
USP Controlled Room Temperature.] Protect from freezing. See insert.

F WR-0318 (8/08)

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label

What's New

No Current Announcements.

Search

Please enter your search term(s) for METRONIDAZOLE